We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




The First European Lab Automation Conference Receives Rave Reviews

By LabMedica International staff writers
Posted on 08 Aug 2011
The first European scientific conference dedicated to advances in laboratory automation was given high marks by both participants and exhibitors.

The European Lab Automation (ELA) conference was held in Hamburg, Germany, from June 30 – July 1, 2011. More...
More than 1,500 scientists attended the conference, which also played host to over 150 commercial exhibitors.

The conference was divided into 10 distinct tracks, which presented the attendees with a vast amount of useful and relevant scientific content across a range of applications within the broad field of laboratory automation. The tracks included advances in biodetection and biosensors; advances in microarray technology; advances in protein crystallography; advances in separation technology; the European Agrigenomics Conference, which responded to the great interest in genetically engineered plants to optimize yields and their use in biofuels, as well as on the alteration of certain genes to increase plant resistance towards disease and infection; Lab-on-a-Chip European Congress, which was designed to review existing and new life science applications of microfluidic technologies; Next-Gen Sequencing Europe Conference; Screening Europe Conference, which dealt with high throughput and high content screening; and the World Biobanking Summit.

Ken Browne, the organizer of the event and director of Select Biosciences (Sudbury, United Kingdom) said, “We are delighted with the success of the first ELA conference and exhibition and have received some fantastic feedback from vendors and delegates alike. We are aiming to fill the need for a pan-European Automation event, and establish ELA as the forum for combining scientific content with up-to-date technology. As such, we have already booked the date for the second ELA conference and hope to continue its success.”

The next ELA conference is scheduled for Hamburg (Germany) on May 30- 31, 2012.

Related Links:
European Lab Automation (ELA) conference
Select Biosciences


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.